MAPK pathway and BRAF status have been widely explored over the last few years showing that the histologic spectrum of low grade gliomas and glioneuronal tumors is vague but individualizing a group of low grade glioma with MAPK signaling pathway deregulation. Here, BRAF is linked to central nervous system cancer.